PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC)

S. Loibl; O. Metzger; S. J. Mandrekar; C. Mundhenke; S. Seiler; P. Valagussa; A. DeMichele; E. Lim; D. Tripathy; E. P. Winer; C. Huang; L. Carey; P. Francis; K. D. Miller; M. P. Goetz; A. Prat; S. Loi; I. Krop; L. Gianni; E. M. Ciruelos

doi:10.1093/annonc/mdy272.357

PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC)

S. Loibl, O. Metzger, S. J. Mandrekar, C. Mundhenke, S. Seiler, P. Valagussa, A. DeMichele, E. Lim, D. Tripathy, E. P. Winer, C. Huang, L. Carey, P. Francis, K. D. Miller, M. P. Goetz, A. Prat, S. Loi, I. Krop, L. Gianni, E. M. Ciruelos

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii121
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy272.357
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy272.357

Cite this

Loibl, S., Metzger, O., Mandrekar, S. J., Mundhenke, C., Seiler, S., Valagussa, P., DeMichele, A., Lim, E., Tripathy, D., Winer, E. P., Huang, C., Carey, L., Francis, P., Miller, K. D., Goetz, M. P., Prat, A., Loi, S., Krop, I., Gianni, L., & Ciruelos, E. M. (2018). PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC). Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii121. https://doi.org/10.1093/annonc/mdy272.357

PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC). / Loibl, S.; Metzger, O.; Mandrekar, S. J. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii121.

Research output: Contribution to journal › Article › peer-review

Loibl, S, Metzger, O, Mandrekar, SJ, Mundhenke, C, Seiler, S, Valagussa, P, DeMichele, A, Lim, E, Tripathy, D, Winer, EP, Huang, C, Carey, L, Francis, P, Miller, KD, Goetz, MP, Prat, A, Loi, S, Krop, I, Gianni, L & Ciruelos, EM 2018, 'PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii121. https://doi.org/10.1093/annonc/mdy272.357

Loibl S, Metzger O, Mandrekar SJ, Mundhenke C, Seiler S, Valagussa P et al. PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC). Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii121. doi: 10.1093/annonc/mdy272.357

Loibl, S. ; Metzger, O. ; Mandrekar, S. J. et al. / PATINA : A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC). In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii121.

@article{ee866f3f9c79443096b15aca072903bf,

title = "PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC)",

author = "S. Loibl and O. Metzger and Mandrekar, {S. J.} and C. Mundhenke and S. Seiler and P. Valagussa and A. DeMichele and E. Lim and D. Tripathy and Winer, {E. P.} and C. Huang and L. Carey and P. Francis and Miller, {K. D.} and Goetz, {M. P.} and A. Prat and S. Loi and I. Krop and L. Gianni and Ciruelos, {E. M.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy272.357",

language = "English (US)",

volume = "29",

pages = "viii121",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - PATINA

T2 - A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC)

AU - Loibl, S.

AU - Metzger, O.

AU - Mandrekar, S. J.

AU - Mundhenke, C.

AU - Seiler, S.

AU - Valagussa, P.

AU - DeMichele, A.

AU - Lim, E.

AU - Tripathy, D.

AU - Winer, E. P.

AU - Huang, C.

AU - Carey, L.

AU - Francis, P.

AU - Miller, K. D.

AU - Goetz, M. P.

AU - Prat, A.

AU - Loi, S.

AU - Krop, I.

AU - Gianni, L.

AU - Ciruelos, E. M.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85078290913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85078290913&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy272.357

DO - 10.1093/annonc/mdy272.357

M3 - Article

C2 - 32136159

SN - 0923-7534

VL - 29

SP - viii121

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib + Anti-HER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this